Summary MdxHealth SA (MdxHealth) is a healthcare company. It develops and commercializes advanced epigenetic assays and service testing for the early detection of cancer and personalized treatment decisions. It offers clinical molecular diagnostics solutions and pharmaco molecular diagnostics solutions. The company's products include ConfirmMDx, which detects absence or presence of prostate cancer; PredictMDx, which indicates patient response to therapy. MdxHealth tests are based on its proprietary MSP methylation technology that assists physicians in the diagnosis of cancer. It also offers biomarker development services to many pharmaceutical companies. MdxHealth markets its products through sales forces, partnerships and distributors. The company has operations in Belgium and the US. MdxHealth is headquartered in Herstal, Belgium. This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. Scope: - The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments - The report analyzes all pipeline products in development for the company MDxHealth SA - The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status) - The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date - The report provides detailed description of products in development, technical specification and functions - The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date. Reasons To Buy: - Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape - Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio - To formulate effective Research & Development strategies - Develop market-entry and market expansion strategies - Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc - Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 5 MDxHealth SA Company Snapshot 6 MDxHealth SA Company Overview 6 MDxHealth SA Pipeline Products and Clinical Trials Overview 7 MDxHealth SA - Pipeline Analysis Overview 9 Business Description 9 Key Facts 9 MDxHealth SA - Major Products and Services 10 MDxHealth SA Pipeline Products by Development Stage 11 MDxHealth SA Pipeline Products Overview 13 AssureMDx - Bladder Cancer 13 AssureMDx - Bladder Cancer Product Overview 13 Bladder ConfirmMDx 14 Bladder ConfirmMDx Product Overview 14 Bladder RecurMdx 15 Bladder RecurMdx Product Overview 15 ClinicalMDx - Cervical Cancer 16 ClinicalMDx - Cervical Cancer Product Overview 16 ConfirmMDx - Lung Cancer 17 ConfirmMDx - Lung Cancer Product Overview 17 InformMDx - Colon Cancer 18 InformMDx - Colon Cancer Product Overview 18 InformMDx - Prostate Cancer 19 InformMDx - Prostate Cancer Product Overview 19 Molecular Diagnostic Test - Bladder Cancer 20 Molecular Diagnostic Test - Bladder Cancer Product Overview 20 Molecular Diagnostic Test - Kidney Cancer 21 Molecular Diagnostic Test - Kidney Cancer Product Overview 21 PharmacoDx - Breast Cancer 22 PharmacoDx - Breast Cancer Product Overview 22 PharmacoDx - Lung Cancer 23 PharmacoDx - Lung Cancer Product Overview 23 PharmacoDx - Ovarian Cancer 24 PharmacoDx - Ovarian Cancer Product Overview 24 PredictMDx - Colon Cancer 25 PredictMDx - Colon Cancer Product Overview 25 MDxHealth SA - Key Competitors 26 MDxHealth SA - Key Employees 27 MDxHealth SA - Key Employee Biographies 28 MDxHealth SA - Locations And Subsidiaries 29 Head Office 29 Other Locations & Subsidiaries 29 Recent Developments 30 MDxHealth SA, Recent Developments 30 May 09, 2016: MDxHealth's ConfirmMDx Stratifies Risk For Aggressive Prostate Cancer 30 May 06, 2016: MDxHealth Announces Positive Data Supporting Prognostic Value of ConfirmMDx for Prostate Cancer 30 May 06, 2016: MDxHealth Announces Positive Data Supporting Prognostic Value of SelectMDx for Prostate Cancer 31 May 03, 2016: MDxHealth Provides First Quarter 2016 Business Update 31 Apr 25, 2016: MDxHealth's SelectMDx Study Published in European Urology 33 Apr 25, 2016: MDxHealth's SelectMDx Study Published in European Urology 33 Mar 29, 2016: MDxHealth Partners with Andros Men's Clinic to Offer SelectMDx for Prostate Cancer 34 Mar 17, 2016: MDxHealth Launches SelectMDx "Liquid Biopsy" Test in the United States 35 Mar 14, 2016: MDxHealth Presents SelectMDx Results from Multicenter Validation Study at the 2016 Annual EAU Congress 35 Mar 09, 2016: MDxHealth Appoints Global Commercial Team for SelectMDx 36 Appendix 38 Methodology 38 About GlobalData 38 Contact Us 38 Disclaimer 38
List of Tables
MDxHealth SA Pipeline Products and Clinical Trials Overview 7 MDxHealth SA Pipeline Products by Equipment Type 7 MDxHealth SA Pipeline Products by Indication 8 MDxHealth SA, Key Facts 9 MDxHealth SA, Major Products and Services 10 MDxHealth SA Number of Pipeline Products by Development Stage 11 MDxHealth SA Pipeline Products Summary by Development Stage 12 AssureMDx - Bladder Cancer - Product Status 13 AssureMDx - Bladder Cancer - Product Description 13 Bladder ConfirmMDx - Product Status 14 Bladder ConfirmMDx - Product Description 14 Bladder RecurMdx - Product Status 15 Bladder RecurMdx - Product Description 15 ClinicalMDx - Cervical Cancer - Product Status 16 ClinicalMDx - Cervical Cancer - Product Description 16 ConfirmMDx - Lung Cancer - Product Status 17 ConfirmMDx - Lung Cancer - Product Description 17 InformMDx - Colon Cancer - Product Status 18 InformMDx - Colon Cancer - Product Description 18 InformMDx - Prostate Cancer - Product Status 19 InformMDx - Prostate Cancer - Product Description 19 Molecular Diagnostic Test - Bladder Cancer - Product Status 20 Molecular Diagnostic Test - Bladder Cancer - Product Description 20 Molecular Diagnostic Test - Kidney Cancer - Product Status 21 Molecular Diagnostic Test - Kidney Cancer - Product Description 21 PharmacoDx - Breast Cancer - Product Status 22 PharmacoDx - Breast Cancer - Product Description 22 PharmacoDx - Lung Cancer - Product Status 23 PharmacoDx - Lung Cancer - Product Description 23 PharmacoDx - Ovarian Cancer - Product Status 24 PharmacoDx - Ovarian Cancer - Product Description 24 PredictMDx - Colon Cancer - Product Status 25 PredictMDx - Colon Cancer - Product Description 25 MDxHealth SA, Key Employees 27 MDxHealth SA, Key Employee Biographies 28 MDxHealth SA, Other Locations 29 MDxHealth SA, Subsidiaries 29
List of Figures
MDxHealth SA Pipeline Products by Equipment Type 8 MDxHealth SA Pipeline Products by Development Stage 11
Global 3D scanning market is expected to be valued at USD 4,900.7 million by 2020, as per a new research report by Radiant Insights, Inc. Increasing need for speedy and precise results with high efficiency is anticipated to drive the industry. 3DRead More...
Global lignin market size is expected to exceed USD 6 billion by 2022, growing at 4.9% from 2015 to 2022. Rising demand for animal feed and potential as a feedstock substitute to crude oil are expected to drive lignin market demand over the forecastRead More...
Global animal feed additives market size was estimated at USD 16 billion in 2014. Growing meat consumption as a key protein source, especially in Asia Pacific and Latin America is expected to be a key driver for market demand over the forecast periodRead More...
Global Biocides market size is likely to be valued at USD 11.9 billion by 2022; as per a new research report by Radiant Insights, Inc. Growth in water treatment process units particularly in China, Japan and India is likely to drive demand. IncreasinRead More...
Global fluorotelomers market size is anticipated to be valued at USD 539.3 million by 2020, as per a new research report by Radiant Insights, Inc. Increasing application scope in fire fighting systems owing to growing safety concerns is likely to driRead More...
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Toll Free: 1-888-928-9744
Email: [email protected]
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.